Composite Resins

Publication Title: 
Malaria Journal

BACKGROUND: Severe malaria results in over a million deaths every year, most of them in children aged less than five years and living in sub-Saharan Africa. Injectable artesunate (AS) was recommended as initial treatment for severe malaria by WHO in 2006. The Walter Reed Army Institute of Research (WRAIR) has been developing a novel good manufacturing practice (GMP) injection of AS, which was approved by the US FDA for investigational drug use and distribution by the CDC.

Miller, Robert Scott
Li, Qigui
Cantilena, Louis R.
Leary, Kevin J.
Saviolakis, George A.
Melendez, Victor
Smith, Bryan
Weina, Peter J.
Subscribe to RSS - Composite Resins